Discover how GLP-1 receptor agonists, a breakthrough in medical science, can help reduce alcohol consumption and improve quality of life. Join the 2nd Opinion podcast with Dr. Paul Kolodzik as he explains the science behind this "miracle drug" and shares insights on its potential to transform addiction treatment. Whether you're seeking new options or curious about cutting-edge health solutions, this episode offers valuable information for a wide audience interested in health, wellness, and innovative therapies. ( Ozempic is a trademark of Novo Nordisk. Dr. Paul Kolodzik has no association with Novo Nordisk )